Portfolio (Quarterly)
Guide ↗
Persistent Asset Partners Ltd
· CIK 0002056052| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | RPRX | ROYALTY PHARMA PLC | Healthcare | 5,178.0 | $248K | 0.09% | -1K | -21.5% | $47.97 | +11.3% |
| 42 | EDU | NEW ORIENTAL ED & TECHNOLOGY | Consumer Defensive | 3,956.0 | $224K | 0.08% | -8K | -66.5% | $56.63 | -8.4% |
| 43 | FHTX | FOGHORN THERAPEUTICS INC | Healthcare | 46,644.0 | $223K | 0.08% | -464.0 | -1.0% | $4.78 | -20.7% |
| 44 | ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | 16,525.0 | $209K | 0.08% | -941.0 | -5.4% | $12.63 | +9.3% |
| 45 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 35,661.0 | $207K | 0.08% | -10K | -21.8% | $5.80 | +10.0% |
| 46 | — | BENITEC BIOPHARMA INC | — | 18,307.0 | $195K | 0.07% | -2K | -11.8% | $10.65 | — |
| 47 | REPL | REPLIMUNE GROUP INC | Healthcare | 25,445.0 | $195K | 0.07% | -36K | -58.6% | $7.65 | -35.6% |
| 48 | ANNX | ANNEXON INC | Healthcare | 33,625.0 | $186K | 0.07% | -60K | -64.1% | $5.54 | -6.0% |
| 49 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 8,884.0 | $186K | 0.07% | -2K | -19.4% | $20.95 | +23.2% |
| 50 | ARGX | ARGENX SE | Healthcare | 253.0 | $185K | 0.07% | -311.0 | -55.1% | $730.25 | +9.5% |
| 51 | — | FORTE BIOSCIENCES INC | — | 6,744.0 | $175K | 0.07% | -3K | -33.5% | $25.90 | — |
| 52 | — | SOLARIS RES INC | — | 15,956.0 | $138K | 0.05% | -10K | -38.9% | $8.62 | — |
| 53 | QURE | UNIQURE NV | Healthcare | 7,887.0 | $129K | 0.05% | -3K | -28.4% | $16.35 | +69.7% |
| 54 | — | AVALO THERAPEUTICS INC | — | 7,918.0 | $118K | 0.04% | -7K | -47.5% | $14.93 | — |
| 55 | MNKD | MANNKIND CORP | Healthcare | 47,394.0 | $116K | 0.04% | -34K | -41.8% | $2.45 | +31.4% |
| 56 | — | LIPOCINE INC NEW | — | 13,442.0 | $107K | 0.04% | -57K | -81.0% | $7.99 | — |
| 57 | URGN | UROGEN PHARMA LTD | Healthcare | 5,824.0 | $105K | 0.04% | -7K | -54.5% | $17.98 | +65.1% |
| 58 | SLB | SLB LIMITED | Energy | 2,000.0 | $103K | 0.04% | -8K | -80.0% | $51.53 | +8.2% |
| 59 | CORT | CORCEPT THERAPEUTICS INC | Healthcare | 2,528.0 | $102K | 0.04% | -23K | -90.2% | $40.31 | +44.6% |
| 60 | HUYA | HUYA INC | Communication Services | 22,273.0 | $74K | 0.03% | -31K | -58.2% | $3.30 | -9.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
48.1%
Healthcare
31.2%
Financial Services
9.4%
Consumer Cyclical
3.6%
Energy
2.8%
Basic Materials
2.2%
Communication Services
2.0%
Industrials
0.4%
Consumer Defensive
0.4%